Understanding Poor Vaccine Responses to Hepatitis B Vaccination

Clinical trial NCT04674462 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04674462
Sponsor: NYU Langone Health
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Vaccine Reaction

Start date: 2022-07-07
Primary completion: 2026-07-01
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.